Aluminium (Al) exposuremay affect the liver of experimental animals. This investigation aimed at evaluating morphological changes in rat liver after a single high dose of Al (as metallic powder suspension). A total of forty female Wistar rats were divided in one exposed and one control group, 20 rats each. The exposed rats received 0.5 mL of sterile physiological suspension of fine Al powder in the concentration of 100 mg mL -1 intraperitoneally (50 mg Al per rat). After 7 weeks all animals were killed (by exsanguination from the abdominal aorta in ether anaesthesia). Liver aluminium was analysed using electrothermal atomic absorption spectrometry. For light microscopy the liver tissue was stained with hematoxylin and eosin, and for histochemical analysis with aurin threecarbocsillic acid (aluminon). Liver Al level was markedly higher in the exposed (37.1 µg g -1 ) than in control rats (0.71 µg g -1
Aluminium (Al) is a silvery white, shiny, extremely reactive metal available everywhere in the environment, in the soil, water and air. It was discovered in 1827, and its production started twenty years later. Today aluminium is used in almost all industrial fields, agriculture, and traffic. Exposure to Al is almost inevitable, since it is present in water, air, and food, as well as in drugs, as an active substance or an additive. It was not until 1975 that Al attracted attention, when the first case of encephalopathy was associated with high quantities of Al in brain cells (1) . This encephalopathy was found in patients on chronic dialysis or in heavily exposed workers (e. g. welders). This encouraged a more intense research of Al toxic effects. Beside the brain, Al in high doses was also shown to damage the kidneys, bones, heart, and lungs (2) (3) (4) (5) .
Hepatotoxic effects of Al were considered less important, despite the fact that Al accumulates in macrophages and in hepatocyte organelles such as lysosomes (3, 6) .
The aim of this study was to assess morphological changes in the liver tissue after parenteral exposure to Al (water suspension of pure Al powder). This research provided additional evidence to our clinical findings in workers occupationally exposed to Al.
MATERIALS AND METHODS
Experimental research was conducted on 40 female two-month-old Wistar rats of similar body weight between 280 g and 320 g. The rats were divided in two groups, 20 in the exposed and 20 in the control group.
The experimental protocol observed the Guide for the Care and Use of Laboratory Animals (7). Rats were kept in cages with a 12-hour light/dark cycle at controlled temperature (21 °C to 25 °C), fed with standard rodent feed, and given tap water ad libitum. During a three-week quarantine no clinical changes in the appearance and/or behaviour were observed. Before the start of the experiment, one animal was killed from each cage, and post mortem findings confirmed that the animals were healthy.
Fine Al powder (aluminium metallic pulvis subtilis by Kemika Zagreb, Croatia) was suspended (100 mg mL -1 ) in a sterile physiological solution, and 0.5 mL of suspension containing 50 mg Al was injected intraperitoneally to each rat in the exposed group. This dose was based on earlier investigations (8, 9) .
Control rats did not receive anything at all. All animals were killed by exsanguination from the abdominal aorta in ether anaesthesia seven weeks after Al administration.
Liver was dissected from each animal and one part used to determine Al mass fraction per gram of wet liver tissue , while the other part was used for histological analysis. Liver tissue Al was determined using a electrothermal atomic absorption spectrophotomer (ET AAS) "Unicam" SP 90 A (10). Statistical differences between the exposed and control groups were analysed using Student's t-test.
For morphological observation by light microscopy liver tissues were fixed in 10 % neutral formaldehyde solution, dehydrated in ascending ethanol series, and embedded in paraffin. Sections were stained with hematoxylin and eosin (H&E), and for histochemical analysis with aurin threecarbocsillic acid (aluminon) using Irwin's method (10, 11) .
The analysis included basic liver structure, portal tracts, acini in sinusoidal and perisinusoidal spaces, and Glisson's capsule.
RESULTS
Average liver Al in the exposed rats was (37.1±14.72) µg g -1 wet weight (N=11) and in controls (0.71± 0.22) µg g -1 wet weight (N=16).
Light microscopy showed that the basic liver structure remained intact. In the exposed rats, portal areas, which were of standard dimensions, had several gently pigmented, Al-positive macrophages (found in 18 of 20 samples). No macrophage was found in control liver samples. In 16 of 20 samples of the exposed and in eight of 20 samples of control rats, bile ductuli were slightly multiplied.
No specific changes were detected in the liver parenchyma in the exposed rats, but micro-vascular fatty changes were found in the hepatocytes of three (of 20) liver samples. No such changes were observed in control rat samples. Sinusoidal and perisinusoidal cells did not show any specific changes.
Glisson's capsule of the exposed rats showed a very strong macrophage reaction that looked like a reaction to a foreign body. It was evidenced by granulomatous changes, in which cells, often gigantic, were infiltrated by black rough Al particles of crystalloid structure. Granulomatous reaction with pigmentation, in fact crystalloid inclusions, was found in the subcapsular liver tissue, including the portal area (Figures 1, 2, and 3 ).
DISCUSSION
In experimental research, Al was administered orally, parenterally and intracranially to laboratory animals, but mainly in the form of Al compounds (12) . In 1979, Ellis et al. (13) injected aluminium chloride intraperitoneally to laboratory rats, and noticed changes in the bones. These results were later confirmed by Goodman et al. (14) in 1984. Tetsuji and Kiyokazu (6) found that after oral administration of aluminium in water solution, Al accumulated in the liver, kidneys, and intestines, but not in the brain, and using an electronic microscope (EDX) they detected an accumulation of Al in lysosomes and vesicles of hepatocytes.
Until now most attention has been paid to experimental research of Al neurotoxic effects. There are a relatively small number of data related to Al toxic effects on the liver functionality and morphology. According to Galle et al. (15) , Al does not produce toxic effects in the liver because it is eliminated from hepatocytes into the bile together with lysosomes.
On the other hand, Abubakar et al. (16) ascertained that Al in hepatocytes, even in small quantities, is associated with an increase in reactive oxygen species and lipid peroxidation. Gonzales et al. (5) pointed out a hepatocyte dysfunctionin terms of reduced in the liver. It penetrated the liver through Glisson's capsule, and lymph.
Furthermore, histochemical staining showed that Al accumulated in phagocytes of the portal area (macrophagocytes and Kupffer cells) as well as in macrophagocytes of the subcapsular area. It was not observed in either the cytoplasm or the organelles of hepatocytes. Even if Al did accumulate in the organelles, and especially in lysosomes, its quantities were too small to be stained by aluminon. Larger particles behaved as a strange body and were immediately overtaken by macrophagocytes. In the capsular and subcapsular area, where Al was detected, the granulomatous reaction was significant.
In addition to changes in Glisson's capsule and in the subcapsular area in the exposed rats, specific changes were also observed in the portal area and acini, which were not seen in the liver of the control animals. These changes included slight microvascular fatty changes, Kupffer cell hyperplasia, and multiplication of bile canalicules, showing that Al reached all liver structures. This suggest that some metal particles passed the macrophagocyte barrier.
CONCLUSION
Our results have demonstrated that Al injected intraperitoneally accumulates in the liver of experimental rats. Only in these rats did we detect morphological changes in the liver tissue such as slight proliferation of bile ductuli and microvesicular steatosis.
Even though abnormal experimental Al exposure such as ours usually does not occur in human beings, our finding may help in further investigations of Al hepatotoxic effects. organic molecule transport over the sinusoidal and bile canalicular membrane, which leads to unbalanced bilirubin and bile acid. Our study has shown that intraperitoneal injection of suspened pure Al significantly increased its concentration in the liver tissue of the exposed rats. This suggest that Al was absorbed and deposited
